1.39
price down icon4.14%   -0.06
after-market Dopo l'orario di chiusura: 1.39
loading
Precedente Chiudi:
$1.45
Aprire:
$1.45
Volume 24 ore:
230.15K
Relative Volume:
0.30
Capitalizzazione di mercato:
$43.58M
Reddito:
-
Utile/perdita netta:
$-69.00M
Rapporto P/E:
-0.50
EPS:
-2.78
Flusso di cassa netto:
$-55.26M
1 W Prestazione:
+5.30%
1M Prestazione:
+12.10%
6M Prestazione:
-74.50%
1 anno Prestazione:
-82.62%
Intervallo 1D:
Value
$1.38
$1.4795
Intervallo di 1 settimana:
Value
$1.33
$1.495
Portata 52W:
Value
$1.05
$10.16

Acrivon Therapeutics Inc Stock (ACRV) Company Profile

Name
Nome
Acrivon Therapeutics Inc
Name
Telefono
617-207-8979
Name
Indirizzo
480 ARSENAL WAY, SUITE 100, WATERTOWN
Name
Dipendente
78
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
ACRV's Discussions on Twitter

Confronta ACRV con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ACRV
Acrivon Therapeutics Inc
1.39 43.58M 0 -69.00M -55.26M -2.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-05 Ripresa Piper Sandler Overweight
2025-01-31 Iniziato KeyBanc Capital Markets Overweight
2024-09-16 Aggiornamento Ladenburg Thalmann Neutral → Buy
2024-04-29 Downgrade Ladenburg Thalmann Buy → Neutral
2024-03-01 Iniziato JMP Securities Mkt Outperform
2023-12-15 Ripresa Jefferies Buy
2023-10-05 Iniziato Maxim Group Buy
2023-06-02 Iniziato Oppenheimer Outperform
2023-05-08 Iniziato BMO Capital Markets Outperform
2023-04-27 Iniziato Ladenburg Thalmann Buy
2023-04-20 Iniziato H.C. Wainwright Buy
2022-12-12 Iniziato Cowen Outperform
2022-12-12 Iniziato Jefferies Buy
2022-12-12 Iniziato Piper Sandler Overweight
Mostra tutto

Acrivon Therapeutics Inc Borsa (ACRV) Ultime notizie

pulisher
Jul 23, 2025

Acrivon Therapeutics Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Acrivon Therapeutics Inc. stockRapid wealth creation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Acrivon Therapeutics Inc. a good long term investmentHigh-octane investment gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How high can Acrivon Therapeutics Inc. stock price go in 2025Smart Money Signals - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Here's Why We're Watching Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Acrivon Therapeutics Inc. stock priceConsistently superior profits - printweek.in

Jul 22, 2025
pulisher
Jul 18, 2025

Is Acrivon Therapeutics Inc. stock a good hedge against inflationSolid Return Trade Selections - beatles.ru

Jul 18, 2025
pulisher
Jul 17, 2025

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 17, 2025
pulisher
Jul 17, 2025

Analysts Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Target Price at $17.71 - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

What makes Acrivon Therapeutics Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Cantor Fitzgerald sets Acrivon stock to Overweight on AP3 platform - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

How Acrivon Therapeutics Inc. stock performs during market volatilityAlpha Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - GlobeNewswire Inc.

Jul 15, 2025
pulisher
Jul 15, 2025

Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionExpert Backed Predictions - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

(ACRV) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 11, 2025

Acrivon Therapeutics (NASDAQ:ACRV) Trading 0.7% Higher – Still a Buy? - Defense World

Jul 11, 2025
pulisher
Jun 22, 2025

Acrivon Therapeutics, Inc.(NasdaqGM: ACRV) dropped from S&P Global BMI Index - MarketScreener

Jun 22, 2025
pulisher
Jun 21, 2025

Learn to Evaluate (ACRV) using the Charts - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 13, 2025

Acrivon Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

Analysts Offer Predictions for ACRV FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Long Term Trading Analysis for (ACRV) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Sells 12,377 Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World

Jun 07, 2025
pulisher
May 31, 2025

Northern Trust Corp Has $706,000 Stock Position in Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World

May 31, 2025
pulisher
May 25, 2025

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 25, 2025

Acrivon Therapeutics Inc Azioni (ACRV) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):